Recent key publications
Edward J Hollox, Ulrike Huffmeier, Patrick L J M Zeeuwen, Raquel Palla, Jesús Lascorz, Diana Rodijk-Olthuis, Peter C M van de Kerkhof, Heiko Traupe, Gys de Jongh, Martin den Heijer, André Reis, John A L Armour & Joost Schalkwijk Psoriasis is associated with increased -defensin genomic copy number.
Nature Genetics doi:10.1038/ng.2007.48
Kamsteeg M, Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Zeeuwen-Franssen ME,
van Erp PE, Schalkwijk J. Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic
dermatitis: regulation by Th2 cytokines.
J Invest Dermatol. 2007 Jul;127(7):1786-9
Zweers MC, Peeters AC, Graafsma S, Kranendonk S, van der Vliet JA, den Heijer
M, Schalkwijk J. Abdominal aortic aneurysm is associated with high serum levels of tenascin-X and
decreased aneurysmal tissue tenascin-X.
Circulation. 2006 Apr 4;113(13):1702-7
Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K,
Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL.
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a
reactive site that is distinct from the legumain-binding site. A novel clue for
the role of cystatin M/E in epidermal cornification.
J Biol Chem. 2006 Jun 9;281(23):15893-9.
de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol. 2005, 125:1163-73.
Zeeuwen, P. L., Vlijmen-Willems, I. M., Olthuis, D., Johansen, H. T., Hitomi, K., Hara-Nishimura, I., Powers, J. C., James, K. E., op den Camp, H. J., Lemmens, R., and Schalkwijk, J.
Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Hum.Mol.Genet. 2004 13(10), 1069-1079.
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., and Bristow, J.2001.
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N.Engl.J. Med. 345(16), 1167-1175.
|